EMR currently have 75.5% ownership of Bullzeye, and that is not under threat, the voting rights of circa 18% of that figure are tapered for 3 years, In addition, another 1% of shares have been switched from Bullzeye to EMR, but these are still reversible. 23.5% of Bullzeye shares remain as Bullzeye shares.
The most negative possible outcome is that the independent report concludes that in the offer, the Chinese shareholders involved in the legal settlement got a favourable deal compared to other Bullzeye shareholders and report puts a value on that, I'm unsure what the possible repercussions of that are.
EMR Price at posting:
$2.59 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)